Page last updated: 2024-09-03

y 27632 and osteoprotegerin

y 27632 has been researched along with osteoprotegerin in 2 studies

Compound Research Comparison

Studies (y 27632)	Trials (y 27632)	Recent Studies (post-2010) (y 27632)	Studies (osteoprotegerin)	Trials (osteoprotegerin)	Recent Studies (post-2010) (osteoprotegerin)
1,924	3	891	5,108	212	2,726

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Stern, PH; Wang, J	1
Galli, C; Lumetti, S; Macaluso, GM; Passeri, G; Piemontese, M; Ravanetti, F	1

Other Studies

2 other study(ies) available for y 27632 and osteoprotegerin

Article	Year
Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA. Journal of cellular biochemistry, 2010, Dec-15, Volume: 111, Issue:6 Topics: Acid Phosphatase; Amides; Animals; Calcitriol; Cell Line; Cell Line, Tumor; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, G12-G13; Isoenzymes; Mice; Osteoblasts; Osteopontin; Osteoprotegerin; Parathyroid Hormone; Pyridines; RANK Ligand; Rats; Reverse Transcriptase Polymerase Chain Reaction; rhoA GTP-Binding Protein; Tartrate-Resistant Acid Phosphatase	2010
Actin cytoskeleton controls activation of Wnt/β-catenin signaling in mesenchymal cells on implant surfaces with different topographies. Acta biomaterialia, 2012, Volume: 8, Issue:8 Topics: Actin Cytoskeleton; Actins; Alkaline Phosphatase; Amides; Animals; beta Catenin; Cell Differentiation; Cell Proliferation; Cells, Cultured; Fluorescent Antibody Technique; Gene Expression Regulation; Luciferases; Mesenchymal Stem Cells; Mice; Osteocalcin; Osteoprotegerin; Prostheses and Implants; Protein Kinase Inhibitors; Pyridines; Real-Time Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger; Surface Properties; Titanium; Wnt Signaling Pathway	2012

Article

Year

Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA.

Journal of cellular biochemistry, 2010, Dec-15, Volume: 111, Issue:6

Topics: Acid Phosphatase; Amides; Animals; Calcitriol; Cell Line; Cell Line, Tumor; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, G12-G13; Isoenzymes; Mice; Osteoblasts; Osteopontin; Osteoprotegerin; Parathyroid Hormone; Pyridines; RANK Ligand; Rats; Reverse Transcriptase Polymerase Chain Reaction; rhoA GTP-Binding Protein; Tartrate-Resistant Acid Phosphatase

2010

Actin cytoskeleton controls activation of Wnt/β-catenin signaling in mesenchymal cells on implant surfaces with different topographies.

Acta biomaterialia, 2012, Volume: 8, Issue:8

Topics: Actin Cytoskeleton; Actins; Alkaline Phosphatase; Amides; Animals; beta Catenin; Cell Differentiation; Cell Proliferation; Cells, Cultured; Fluorescent Antibody Technique; Gene Expression Regulation; Luciferases; Mesenchymal Stem Cells; Mice; Osteocalcin; Osteoprotegerin; Prostheses and Implants; Protein Kinase Inhibitors; Pyridines; Real-Time Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger; Surface Properties; Titanium; Wnt Signaling Pathway

2012